1 |
vitamin K antagonists
(1081 times)
|
Vascular Diseases (249 times)
|
AF (378 times) DOACs (296 times) NOACs (272 times)
|
2004 Non-fatal major bleeding during treatment with vitamin K antagonists: influence of soluble thrombomodulin and mutations in the propeptide of coagulation factor IX.
|
2 |
vitamin K antagonist anticoagulants
(7 times)
|
Internal Medicine (1 time)
|
AF (4 times) NOACs (4 times) DOACs (2 times)
|
2015 Efficacy and Safety of Non-Vitamin K Antagonist Oral Anticoagulants versus Vitamin K Antagonist Oral Anticoagulants in Patients Undergoing Radiofrequency Catheter Ablation of Atrial Fibrillation: A Meta-Analysis.
|
3 |
anti-vitamin K agents
(1 time)
|
Chemistry (1 time)
|
BMD (1 time) DOACs (1 time) LMWHs (1 time)
|
2019 Anticoagulants and Osteoporosis.
|
4 |
enoxaparin-vitamin K antagonists
(1 time)
|
Hematology (1 time)
|
---
|
2015 Risk of major bleeding in patients with venous thromboembolism treated with rivaroxaban or with heparin and vitamin K antagonists.
|
5 |
Vit K antagonists
(1 time)
|
Cardiology (1 time)
|
AF (1 time) DOACs (1 time) HHF (1 time)
|
2018 Better clinical outcome with direct oral anticoagulants in hospitalized heart failure patients with atrial fibrillation.
|
6 |
vitamin K analogues
(1 time)
|
Health Services (1 time)
|
CAT (1 time) DOACs (1 time) IDPTP (1 time)
|
2017 Advances in managing and preventing thromboembolic disease in cancer patients.
|
7 |
vitamin K anticoagulants
(1 time)
|
Medicine (1 time)
|
NOACs (1 time) OCTA (1 time)
|
2018 The potential for evaluating the effects of intensified antithrombotic therapy using retinal optical coherence tomography angiography.
|
8 |
vitamin K inhibitors
(1 time)
|
Drug Therapy (1 time)
|
ADRs (1 time) DOACs (1 time)
|
2019 What are the Characteristics of Patients Experiencing Adverse Drug Reactions to Oral Anticogulants and How Can Such Reactions be Prevented?
|
9 |
vitamin K oral anticoagulants
(1 time)
|
Family Practice (1 time)
|
DOACs (1 time) LVT (1 time) TTE (1 time)
|
2019 Use of dabigatran for treatment of left ventricular thrombus: A tertiary care center experience.
|
10 |
Vitamin K-dependent antagonists
(1 time)
|
Cardiology (1 time)
|
NOACs (1 time)
|
2016 Real Data on Effectiveness, Tolerability and Safety of New Oral Anticoagulant Agents: Focus on Dabigatran.
|
11 |
vitamin K-dependent anticoagulants
(1 time)
|
Medicine (1 time)
|
INR (1 time) SSA (1 time) TTR (1 time)
|
2022 Vitamin K-dependent anticoagulant use and level of anticoagulation control in sub-Saharan Africa: protocol for a retrospective cohort study.
|
12 |
vitamin K-dependent, drugs interfering with the effects of the vitamin
(1 time)
|
Hematology (1 time)
|
ACS (1 time) NOACs (1 time) TXA2 (1 time)
|
2015 Individualized antithrombotic therapy.
|